Ekso Bionics Holdings, Inc. (EKSO)

Market Cap	10.68M
Revenue (ttm)	17.54M
Net Income (ttm)	-10.79M
Shares Out	24.82M
EPS (ttm)	-0.49
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	78,047
Open	0.4278
Previous Close	0.4269
Day's Range	0.4200 - 0.4444
52-Week Range	0.3440 - 1.5300
Beta	1.09
Analysts	Strong Buy
Price Target	2.50 (+481.13%)
Earnings Date	May 5, 2025

About EKSO

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot ort...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2005
• Employees: 66
• Stock Exchange: NASDAQ
• Ticker Symbol: EKSO
• Website: https://www.eksobionics.com

Financial Performance

In 2024, Ekso Bionics Holdings's revenue was $17.93 million, a decrease of -1.94% compared to the previous year's $18.28 million. Losses were -$11.33 million, -25.45% less than in 2023.

Analyst Forecast

According to 2 analysts, the average rating for EKSO stock is "Strong Buy." The 12-month stock price forecast is $2.5, which is an increase of 481.13% from the latest price.

Price Target

$2.5

(481.13% upside)

Analyst Consensus: Strong Buy